GENE ONLINE|News &
Opinion
Blog

Immunotherapy
FDA Boxed Warning for CAR-T therapy, Affecting Bristol-Myers Squibb, Novartis, Janssen, Gilead Sciences
2024-01-24
Moderna To Collaborate With Harbour BioMed On Nucleic Acid-Based Cancer Therapies
2022-11-14
Zenas Picks Up $118 Million To Advance Phase 3 For Autoimmune Candidate
2022-11-10
Kura Oncology Boasts Immunotherapy Preliminary Trial Data Success
2022-10-26
Eucure Biopharma, Syncromune To Develop Intratumoral Immunotherapy
2022-10-20
FDA Drops New Oncology Development Guidelines
2022-10-18
CHMP Gives Kite’s Lymphoma Immunotherapy a Positive Opinion
2022-09-16
Dren Bio Draws $65 Million, Aiming for Phase 1 of ADCC Lead
2022-06-15
Europe Okays Roche’s CAR-T Competitor for Blood Cancer
2022-06-09
Antitumor Response of Left-handed Z-DNA Reinvigorates Immunotherapy’s Efficacy
2022-06-02
Novartis CAR-T Cell Therapy Receives FDA Approval for Third Indication to Treat Follicular Lymphoma
2022-05-30
Stanford Touts Remote-Controllable CAR-T Cell Therapy
2022-05-26
These Companies Are Harnessing Oncolytic Viruses to Target Cancer
2022-05-25
EU Expands Merck’s Keytruda Use on Breast Cancer
2022-05-25
AbbVie’s Big Moves; Expanding with One Company, Cutting Ties with Another
2022-04-21
1 2 3 7
LATEST
New Regulatory Measures in China A First in the Fight Against Sedentary Behavior in Children
2024-05-24
Cure Genetics Announced Promising Safety and Efficacy Data of CAR-NKT Product CGC729 for RCC at ASGCT 2024
2024-05-23
AstraZeneca’s $1.5 Billion ADC Manufacturing Facility in Singapore
2024-05-23
Hims & Hers Health Inc. Tipping the Scales of the Weight Loss Market — and Wall Street is Loving it!
2024-05-22
GV Announces Cooperation with CICC
2024-05-22
Eli Lilly and Aktis Oncology Partner to Advance Novel Radiopharmaceuticals
2024-05-22
Preventive Medicine for Neurodegeneration on the Rise: New Breakthrough in Routine Blood Testing for Alzheimer’s Disease
2024-05-20
EVENT
Scroll to Top